MedTrace Logo

Managing Dry Eye in Patients Using Glaucoma Drops

NCT06158984 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-12-27

No results posted yet for this study

Summary

A single center randomized controlled trial on managing dry eye signs and symptoms in patients using anti-glaucoma eye drops.

Conditions

  • Dry Eye

Interventions

DEVICE

IPL

Intense pulse light (IPL) therapy is used for the treatment of drug-related dry eye in glaucoma patients.

Sponsors & Collaborators

  • He Eye Hospital

    lead OTHER

Principal Investigators

  • Emmanuel Eric Pazo · He Eye Hospital, Shenyang, China

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2023-12-01
Completion
2023-12-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158984 on ClinicalTrials.gov